Browse > Article
http://dx.doi.org/10.5483/BMBRep.2010.43.4.297

Baicalein and wogonin inhibit collagen deposition in SHR and WKY cardiac fibroblast cultures  

Kong, Ebenezer K.C. (Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong)
Huang, Yu (Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong)
Sanderson, John E. (Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong)
Chan, Kar-Bik (Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong)
Yu, Shan (Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong)
Yu, Cheuk-Man (Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong)
Publication Information
BMB Reports / v.43, no.4, 2010 , pp. 297-303 More about this Journal
Abstract
In order to demonstrate the potential therapeutic effect of two flavonoids, Baicalein and Wogonin, on suppression of pathological myocardial fibrosis in hypertension, we investigated their in vitro effects on collagen expression in primary cultured cardiac fibroblasts isolated from neonatal normotensive (WKY) and hypertensive (SHR) rats. Our results showed that over-expression of collagen mRNA and protein induced in cardiac fibroblasts by angiotensin (AngII) could be attenuated significantly by both flavonoids at an optimal dosage ($30\;{\mu}M$; P < 0.01). Results of immunoblots showed that expression of 12-LO level, p-ERK/ ERK ratio and MMP-9 in AngII-stimulated SHR cardiac fibroblasts were significantly down-regulated by both flavonoids. Our results show that both Baicalein and Wogonin can suppress collagen deposition in AngII-stimulated SHR and WKY cardiac fibroblasts.
Keywords
Baicalein; Cardiac fibroblast; Collagen; Fibrosis; Wogonin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Yu, C. M., Tipoe, G. L., Lai, K. W. H. and Lau, C. P. (2001) Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J. Am. Coll. Cardiol. 38, 1207-1215   DOI   ScienceOn
2 Wen, Y., Nadler, J. L., Gonzales, N., Scott, S., Clauser, E. and Natarajan, R. (1996) Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase. Am. J. Physiol. 271, C1212-1220   DOI   PUBMED
3 Robert, V., Besse, S., Sabri, A., Silvestre, J. S., Assayag, P., Nguyen, V. T., Swynghedauw, B. and Delcayre, C. (1997) Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab. Invest. 76, 729-738   PUBMED
4 Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jr., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., Jr. and Roccella, E. J. (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J. Am. Med. Assoc. 289, 2560-2572   DOI   ScienceOn
5 Zhang, Z. P., Wang, L. J. and Yao, Q. H. (2007) Expression of Saccharomyces cerevisiae Hem1 recombined with Arabidopsis thaliana HemA1 promoter in transgenic tobacco. Acta. Bot. Boreal.-Occident. Sin. 27, 1929-1936. (in Chinese with English abstract)
6 Zhang, Z. P., Wang, L. J. and Yao, Q. H. (2008) Study on leaf photosynthesis and chlorophyll fluorescence of transgenic tobacco over-producing 5-aminolevulinic acid (ALA). Acta. Bot. Boreal.-Occident. Sin. 28, 1196-1202. (in Chinese with English abstract)
7 Shimizu, I., Ma, Y. R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., Kawada, N., Hori, H. and Ito, S. (1999) Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29, 149-160   DOI   ScienceOn
8 Schorb, W., Conrad, K. M., Singer, H. A., Dostal, D. E. and Baker, K. M. (1995) Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J. Mol. Cell. Cardiol. 27, 1151-1160   DOI   ScienceOn
9 Munshi, H. G., Wu, Y. I., Mukhopadhyay, S., Ottaviano, A. J., Sassano, A., Koblinski, J. E., Platanias, L. C. and Stack, M. S. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279, 39042-39050   DOI   ScienceOn
10 Graham, H. K. and Trafford, A. W. (2007) Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure. Am. J. Physiol. Heart Circ. Physiol. 292, H1364-1372   DOI   ScienceOn
11 Fullerton, M. J. and Funder, J. W. (1994) Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc. Res. 28, 1863-1867   DOI   ScienceOn
12 Vellaichamy, E., Khurana, M. L., Fink, J. and Pandey, K. N. (2005) Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J. Biol. Chem. 280, 19230-19242   DOI   ScienceOn
13 Junquiera, L. C., Junqueira, L. C. and Brentani, R. R. (1979) A simple and sensitive method for the quantitative estimation of collagen. Anal. Biochem. 94, 96-99   DOI   ScienceOn
14 Kim, S. and Iwao, H. (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52, 11-34   PUBMED
15 Levick, S. P., Loch, D. C., Taylor, S. M. and Janicki, J. S. (2007) Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J. Immunol. 178, 641-646   DOI   PUBMED   ScienceOn
16 Brilla, C. G., Matsubara, L. and Weber, K. T. (1996) Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension 28, 269-275   DOI   PUBMED   ScienceOn
17 Miki, T., Miura, T., Nishino, Y., Yano, T., Sakamoto, J., Nakamura, Y., Ichikawa, Y., Ikeda, Y., Kobayashi, H., Ura, N. and Shimamoto, K. (2004) Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin. Exp. Pharmacol. Physiol. 31, 873-882   DOI   ScienceOn
18 Puchtler, H., Meloan, S. N. and Waldrop, F. S. (1988) Are picro-dye reactions for collagens quantitative? Chemical and histochemical considerations. Histochemistry 88, 243-256   PUBMED
19 Brilla, C. G., Rupp, H., Funck, R. and Maisch, B. (1995) The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur. Heart J. 16, 107-109   PUBMED
20 Huang, Y., Tsang, S. Y., Yao, X. and Chen, Z. Y. (2005) Biological properties of baicalein in cardiovascular system. Curr. Drug Targets. Cardiovasc. Haematol. Disord. 5, 177-184   DOI   ScienceOn
21 Fedak, P. W., Verma, S., Weisel, R. D. and Li, R. K.(2005) Cardiac remodeling and failure From molecules to man (Part II). Cardiovasc. Pathol. 14, 49-60   DOI   ScienceOn
22 Rouet-Benzineb, P., Gontero, B., Dreyfus, P. and Lafuma, C. (2000) Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J. Mol. Cell. Cardiol. 32, 1767-1778   DOI   ScienceOn
23 Li, Y. Y., McTiernan, C. F. and Feldman, A. M. (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 46, 214-224   DOI   ScienceOn
24 Morales, M. O., Price, R. L. and Goldsmith, E. C. (2005) Expression of discoidin domain receptor 2 (DDR2) in the developing heart. Microsc. Microanal. 11, 260-267   DOI   PUBMED   ScienceOn
25 Matsubara, L. S., Matsubara, B. B., Okoshi, M. P., Franco, M. and Cicogna, A. C. (1997) Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats. Can. J. Physiol. Pharmacol. 75, 1328-1334   DOI   ScienceOn
26 Ono, M., Miyamura, M., Kyotani, S., Saibara, T., Ohnishi, S. and Nishioka, Y. (1999) Effects of Sho-saiko-to extract on liver fibrosis in relation to the changes in hydroxyproline and retinoid levels of the liver in rats. J. Pharm. Pharmacol. 51, 1079-1084   DOI   PUBMED
27 Li, Z., Tran, T. T., Ma, J. Y., O'Young, G., Kapoun, A. M., Chakravarty, S., Dugar, S., Schreiner, G. and Protter, A. A. (2004) p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J. Cardiovasc. Pharmacol. 44, 486-492   DOI   ScienceOn
28 Yang, J., Zhang, S., Zhou, Q., Guo, H., Zhang, K., Zheng, R. and Xiao, C. (2007) PKHD1 Gene silencing may cause cell abnormal proliferation through modulation of intracellular calcium in autosomal recessive polycystic kidney disease. J. Biochem. Mol. Biol. 40, 467-474   DOI   PUBMED
29 Chen, K., Chen, J., Li, D., Zhang, X. and Mehta, J. L. (2004) Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44, 655-661   DOI   ScienceOn
30 Weber, K. T. and Brilla, C. G. (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin- angiotensin-aldosterone system. Circulation 83, 1849-1865   DOI   PUBMED   ScienceOn
31 Murasawa, S., Mori, Y., Nozawa, Y., Gotoh, N., Shibuya, M., Masaki, H., Maruyama, K., Tsutsumi, Y., Moriguchi, Y., Shibazaki, Y., Tanaka, Y., Iwasaka, T., Inada, M. and Matsubara, H.(1998) Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by $Ca^{2+}$/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ. Res. 82, 1338-1348   DOI   PUBMED   ScienceOn
32 Weber, K. T., Sun, Y., Guarda, E., Katwa, L. C., Ratajska, A., Cleutjens, J. P. and Zhou, G. (1995) Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory mechanisms. Eur. Heart J. 16(Suppl C), 24-28   DOI
33 Weber, K. T., Janicki, J. S., Shroff, S. G., Pick, R., Chen, R. M. and Bashey, R. I. (1988) Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ. Res. 62, 757-765   DOI   PUBMED   ScienceOn
34 Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408   DOI   ScienceOn
35 Horiuchi, M., Akishita, M. and Dzau. V. J. (1999) Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33, 613-621   DOI   PUBMED   ScienceOn
36 Brilla, C. G., Matsubara, L. S. and Weber, K. T. (1993) Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J. Mol. Cell. Cardiol. 25, 563-575   DOI   ScienceOn
37 Wang, Z. Q., Moore, A. F., Ozono, R., Siragy, H. M. and Carey, R. M. (1998) Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension 32, 78-83   DOI   PUBMED   ScienceOn
38 Shivakumar, K., Dostal, D. E., Boheler, K., Baker, K. M. and Lakatta, E. G. (2003) Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. Am. J. Physiol. Heart Circ. Physiol. 284, H1454-1459   DOI   PUBMED   ScienceOn
39 Wen, Y., Gu, J., Liu, Y., Wang, P. H., Sun, Y. and Nadler, J. L. (2001) Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth. Circ. Res. 88, 70-76   DOI   PUBMED   ScienceOn